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Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USAThe brain has traditionally been considered an immune privileged
organ, in part due to the lack of evidence for lymphatic vasculature
(Galea et al., 2007). Two centuries ago, the existence of lymphatic ves-
sels on the surface of the human brain was proposed but it has since
been widely dismissed (Lukic et al., 2003). Therefore, while T cells
leave all other organs via the lymphatic system to reach nearby lymph
nodes, the prevailing view has been that inﬁltrated T cells exit the
brain via venous blood circulation, circumventing the lymph nodes
(Ransohoff and Engelhardt, 2012). The recent evidence for the existence
of a lymphatic vascular system in the brain's meninges provided inde-
pendently by two labs, ﬁrst by the Kipnis lab (Louveau et al., 2015)
and then by the Alitalo lab (Aspelund et al., 2015), challenges this
view and raises the intriguing possibility of an alternative gateway for
T cells to egress the brain.
The key for identifying these meningeal lymphatic vessels by both
labs was the use of a whole-mount preparation where the meninges
were ﬁxed while still attached to the skull, thus enabling the preserva-
tion of ﬁnemeningeal vessels. Kipnis' lab identiﬁed a rather simple net-
work of narrow vessels with a distinct lumen that ran along the blood
vessels in the superior sagittal and transverse sinuses on the top of
the brain and importantly, expressed multiple molecular hallmarks of
lymphatic endothelial cells including lymphatic vessel endothelial
hyaluronan receptor 1 (Lyve-1) and vascular endothelial growth factor
receptor 3 (VEGFR3). Alitalo's lab additionally described that this
lymphatic network becomes more extensive at the base of the brain,
where it contains lymphatic valves, and exits the skull alongside the
cranial nerves. The anatomical and cellular classiﬁcation of these men-
ingeal vessels was strengthened by complimentary experiments from
both labs demonstrating functional implications of VEGFR3. Injections
of a VEGFR3 ligand, VEGF-c, into the cerebrospinal ﬂuid (CSF) resulted
in an increased diameter of themeningeal lymphatic vessels. Converse-
ly, mice with impaired VEGFR3-VEGF-c signaling showed a complete
absence of meningeal lymphatic vessels indicating that these vessels,
like peripheral lymphatic vessels, are functionally regulated by VEGFR3.
An essential functional characteristic of lymphatic vasculature is
permissiveness to ﬂuid and drainage to lymph nodes. In line with this,
dyes injected into the CSF were detected both in the lumen of Lyve-1-
expressing vessels and in the deep cervical lymphnodes (dcLN),where-
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lymph nodes and additionally, increased the diameter of the meningeal
lymphatic vessels, indicating that these vessels drain to the dcLN. The
Alitalo lab further demonstrated that dye injected into the brain paren-
chyma was absorbed by lymphatic vessels and preferentially drained
into the ipsilateral dcLN from the base of the brain. Surprisingly, Kipnis'
lab excluded the best-known route of drainage into the dcLN, via the
nasal cavity's cribriform plate and the nasal mucosa (Kida et al., 1995),
as they failed to see dcLN drainage of dye injected into the nasalmucosa.
In contrast, the Alitalo lab's elaborate imaging studies indicated that
lymphatic vessels indeed pass through the skull in the meningeal lining
of the cribriformplate and into the nasalmucosa, corroborating thenasal
drainage route as one of many possible passages to the dcLN. Hence, fu-
ture researchwill be required tomap out the extent of this newly discov-
ered lymphatic system and its relationship to the rest of the lymphatic
circuitry in the body. This may be particularly important given that
disrupting drainage of excess ﬂuids in the peripheral lymphatic system
leads to peripheral lymphedemawhich affects millions of people world-
wide. Interestingly, blocking drainage to the dcLN has been shown to
exacerbate ischemic-evoked edema in rats (Si et al., 2006), raising the
question whether the meningeal lymphatic system plays a critical
role in reducing brain edema. This possibility should be considered in
future scientiﬁc discussions both in basic and clinical sciences.
One intriguing question that remains is whether the lymphatic
vessels act as a cellular afferent route out of the brain, allowing T cells
to circulate through themeninges and to thedcLN. In their study, Kipnis'
lab observed a ten-fold higher density of T cells that aligned within the
lumen of Lyve-1-expressing vessels compared to that of blood vessels.
Importantly, removal of the dcLN increased the density of T cells in
the meninges, indicating that drainage to the dcLN might be crucial
for T cells to egress. While these data suggest that meningeal lymphatic
vessels contain T cells, more experiments are necessary to demonstrate
whether T cells indeed are circulating via these vessels. Interestingly,
metastasis from primary brain tumors (e.g., gliomas) has been found
in the dcLN (Mondin et al., 2010), supporting the notion of a direct cel-
lular route. It would be very interesting to investigate the ﬂow of T cells
in meningeal lymphatic vessels during infection and inﬂammation and
to determine ﬂuctuation in number of T cells drawn to (and out of) the
brain parenchyma which potentially would change our understanding
of T cell circulation in the brain.
The functional implications of this newly discovered lymphatic
network in both health and disease are broad and raise many exciting
questions. Of particular interest would be how this newly discovered
meningeal lymphatic system relates to the recently described glymphatic
777L. Dissing-Olesen et al. / EBioMedicine 2 (2015) 776–777system, which potentiates waste clearance from the brain by facilitating
the ﬂux of CSF across the brain parenchyma (Iliff et al., 2012). It will be
interesting to investigate if and howpathological agents, such as amyloid
β are transported between the glymphatic and lymphatic systems. For
example, would removal of amyloid β and other misfolded proteins
from the brain parenchyma be reduced inmicewith an impairedmenin-
geal lymphatic system (e.g., following removal of the dcLN or in VEGFR3-
deﬁcient mice)? Domeningeal lymphatic defects correlate with or cause
enhanced risk of patients developing neurodegenerative diseases such as
Alzheimer's and Parkinson's disease?
Arguably the most appealing aspect of the existence of meningeal
lymphatic vessels is the insight it provides about the circulation of
T cells in the brain. Immune cells and immune-relatedmolecules are in-
creasingly recognized to play crucial roles in brain wiring in both devel-
opment and disease. Interestingly, Kipnis' lab has previously shown that
removal of dcLN can induce learning and memory impairments in mice
(Radjavi et al., 2014), suggesting that disrupting T cell circulation has
gross behavioral consequences. Mapping the cellular lymphatic route
and understanding its potential role in behavioral paradigms such as
learning andmemory, sleep, and stress will advance our understanding
of communication between the central nervous systemand the immune
system. Furthermore, elucidating a potential path for T cell circulation
could potentially unveil new therapeutic targets for interventions
in neurodegenerative diseases and neurological disorders, including
those considered to be triggered by inﬂammatory responses, such as
multiple sclerosis.
These exciting new ﬁndings have reopened the discussion about to
what degree the brain is immune privileged by revealing a potential
lymphatic gateway for T cells to egress the brain.Conﬂicts of Interest
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